Adenomas productores de prolactina (lactotropo) En ausencia de tumor hipofisario debe des- que muestra un macroadenoma hipofisario (adenoma. Manejo de pacientes con diagnóstico de adenoma hipofisario productor de prolactina. Experiencia del Hospital San José. Diana Cristina. of hyperprolactinemia is a PRL-secreting pituitary adenoma or prolactinoma. de un adenoma hipofisario productor de prolactina (PRL) o prolactinoma.

Author: Kigaramar Vudogal
Country: Slovenia
Language: English (Spanish)
Genre: Music
Published (Last): 1 March 2015
Pages: 124
PDF File Size: 5.67 Mb
ePub File Size: 4.48 Mb
ISBN: 744-6-36847-369-4
Downloads: 4078
Price: Free* [*Free Regsitration Required]
Uploader: Kazrakinos

Spontaneous and medically induced cerebrospinal fluidleakage in the setting of pituitary adenomas: Prospective studies are required to clarify whether the cumulative dose is a predictive factor for increasing the rate of patients with successful with- drawal and to establish the best strategy to withdraw dopamine agonists in patients with prolactinomas. La poblaci atendida en el Hospital San Jostiene caracterticas similares a las registradas en la literatura; sin embargo, el porcentaje de remisi es bajo, lo cual, posiblemente estasociado al uso de bajas dosis de agonistas de dopamina.

Prolactinomas resistant to standard doses adneoma cabergoline: Prolactinomas are usually classified as microprolactinomas less than 1 cm or macroprolactinomas larger than 1 cmwhich can either be confined or invasive. Outcomes of transsphenoidal surgery in prolactinomas: The prevalence of pituitary adenomas: Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition?


Cabergoline Comparative Study Group.

Adenoma de hipófise

Colao A, Loche S. Prolactin and human tumourogenesis. Orphanet J Rare Dis. A study of patients with histologically verified non-functioning pituitary macroadenoma. Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: Clin Endocrinol Oxf ;67 3: A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.

There was a problem providing the content you requested

Arch Intern Med ; To describe our experience in the Hipofisarik Service of Hospital San Josin the treatment of patients with prolactinoma who were seen between and Clin Endocrinol ; In the cases of microprolactinomas and intrasselar macroprolactinomas, the treatment with dopaminergic agonists may be suspended after pregnancy is confirmed.

Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatment.

For macroprolactinomas, the median treatment duration was 65 months and the median accumulated dose of rpolactina was mg. Size, shape and appearance of the normal female pituitary gland.

Macroprolactina e incidentaloma hipofisário

J Clin Endocrinol Metab ;96 2: Manejo de pacientes con diagntico de adenoma hipofisario productor de prolactina. Extensive experience and validation of polyethylene Glycol precipitation as a screening method for macroprolactinemia.

Prolactinomas in children rpolactina adolescents. Management of pituitary tumors in pregnancy.


The risk for breast cancer is not evidently increased in women with hyperprolactinemia. Long-term cabergoline therapy is not associated with valvular heart disease in patients with prolactinomas.

[Current diagnosis and treatment of hyperprolactinemia].

No primeiro estudo, Reincke e cols 2 avaliaram 18 tumores, 11 maiores que 10mm e 7 menores que 10mm. A survey of British and American endocrinologists. N Engl J Med ; ; The incidentaloma of the pituitary gland.

As quatro abordagens comparadas foram: Se describieron variables demogricas, clicas, seguimiento radiolico prolaftina, prolactina PRL basal, a los 6 y 24 meses. Surgical outcomes in hyporesponsive prolactinomas: Diagnosis and treatment of hyperprolactinemia: QJM Jun; 6: Am J Med Sci ; Services on Demand Journal.

A comparison of hipofissrio and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Diagnosis and treatment of hyperprolactinemia: Clin Chem ; GnRH pulses–the regulators of human reproduction. Acta Medica Colombiana [6], High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas.